Literature DB >> 17640604

Experimental anti-GBM disease as a tool for studying spontaneous lupus nephritis.

Yuyang Fu1, Yong Du, Chandra Mohan.   

Abstract

Lupus nephritis is an immune-mediated disease, where antibodies and T cells both play pathogenic roles. Since spontaneous lupus nephritis in mouse models takes 6-12 months to manifest, there is an urgent need for a mouse model that can be used to delineate the pathogenic processes that lead to immune nephritis, over a quicker time frame. We propose that the experimental anti-glomerular basement membrane (GBM) disease model might be a suitable tool for uncovering some of the molecular steps underlying lupus nephritis. This article reviews the current evidence that supports the use of the experimental anti-GBM nephritis model for studying spontaneous lupus nephritis. Importantly, out of about 25 different molecules that have been specifically examined in the experimental anti-GBM model and also spontaneous lupus nephritis, all influence both diseases concordantly, suggesting that the experimental model might be a useful tool for unraveling the molecular basis of spontaneous lupus nephritis. This has important clinical implications, both from the perspective of genetic susceptibility as well as clinical therapeutics.

Entities:  

Mesh:

Year:  2007        PMID: 17640604     DOI: 10.1016/j.clim.2007.05.007

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  33 in total

1.  Neutrophil gelatinase-associated lipocalin is instrumental in the pathogenesis of antibody-mediated nephritis in mice.

Authors:  Rahul D Pawar; Milena Pitashny; Simona Gindea; Arlene Tan Tieng; Benjamin Levine; Beatrice Goilav; Sean R Campbell; Yumin Xia; Xiaoping Qing; David B Thomas; Leal Herlitz; Thorsten Berger; Tak W Mak; Chaim Putterman
Journal:  Arthritis Rheum       Date:  2012-05

2.  Cutting edge: protein phosphatase 2A confers susceptibility to autoimmune disease through an IL-17-dependent mechanism.

Authors:  José C Crispín; Sokratis A Apostolidis; Florencia Rosetti; Marton Keszei; Ninghai Wang; Cox Terhorst; Tanya N Mayadas; George C Tsokos
Journal:  J Immunol       Date:  2012-03-14       Impact factor: 5.422

Review 3.  Novel therapeutic approaches to lupus glomerulonephritis: translating animal models to clinical practice.

Authors:  Harini Bagavant; Kambiz Kalantarinia; Yogesh Scindia; Umesh Deshmukh
Journal:  Am J Kidney Dis       Date:  2011-01-15       Impact factor: 8.860

4.  Heightened cleavage of Axl receptor tyrosine kinase by ADAM metalloproteases may contribute to disease pathogenesis in SLE.

Authors:  Jacob J Orme; Yong Du; Kamala Vanarsa; Jessica Mayeux; Li Li; Azza Mutwally; Cristina Arriens; Soyoun Min; Jack Hutcheson; Laurie S Davis; Benjamin F Chong; Anne B Satterthwaite; Tianfu Wu; Chandra Mohan
Journal:  Clin Immunol       Date:  2016-05-27       Impact factor: 3.969

5.  From the Large Scale Expression Analysis of Lupus Nephritis to Targeted Molecular Medicine.

Authors:  Celine C Berthier; Matthias Kretzler; Anne Davidson
Journal:  J Data Mining Genomics Proteomics       Date:  2012-03-27

6.  Human lupus serum induces neutrophil-mediated organ damage in mice that is enabled by Mac-1 deficiency.

Authors:  Florencia Rosetti; Naotake Tsuboi; Kan Chen; Hiroshi Nishi; Thomas Ernandez; Sanjeev Sethi; Kevin Croce; George Stavrakis; Jorge Alcocer-Varela; Diana Gómez-Martin; Nico van Rooijen; Vasileios C Kyttaris; Andrew H Lichtman; George C Tsokos; Tanya N Mayadas
Journal:  J Immunol       Date:  2012-08-29       Impact factor: 5.422

7.  An essential role of interleukin-17 receptor signaling in the development of autoimmune glomerulonephritis.

Authors:  Kritika Ramani; Sudesh Pawaria; Kelly Maers; Anna R Huppler; Sarah L Gaffen; Partha S Biswas
Journal:  J Leukoc Biol       Date:  2014-06-16       Impact factor: 4.962

8.  Poly(ADP-ribose) polymerase-1 regulates the progression of autoimmune nephritis in males by inducing necrotic cell death and modulating inflammation.

Authors:  Neelakshi R Jog; Joudy-Ann Dinnall; Stefania Gallucci; Michael P Madaio; Roberto Caricchio
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

9.  Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis.

Authors:  Anna-Marie Fairhurst; Chun Xie; Yuyang Fu; Andrew Wang; Christopher Boudreaux; Xin J Zhou; Ricardo Cibotti; Anthony Coyle; John E Connolly; Edward K Wakeland; Chandra Mohan
Journal:  J Immunol       Date:  2009-10-28       Impact factor: 5.422

10.  The lupus-susceptibility gene kallikrein downmodulates antibody-mediated glomerulonephritis.

Authors:  Q-Z Li; J Zhou; R Yang; M Yan; Q Ye; K Liu; S Liu; X Shao; L Li; X-J Zhou; E K Wakeland; C Mohan
Journal:  Genes Immun       Date:  2009-03-05       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.